AGP Executive Report

Mental Health Access: France’s health minister says youth mental health care will be fast-tracked, aiming to get support to at-risk young people within days. Obesity Drugs: France becomes the first EU country to reimburse anti-obesity weight-loss drugs for severely obese patients, with coverage starting mid-June—an important shift for long-term care and access. AI & Environment: A UN report urges AI firms to disclose carbon, water and land footprints, warning the AI boom is stressing power grids and resources. AI Misinformation: A new test finds pro-Russian narratives can still slip into chatbot answers, with some tools repeating false claims as fact. Tech Sovereignty: The EU unveils a package to reduce dependence on US and Asian cloud/AI, including favouring European firms in sensitive public contracts. Public Health & Safety: Kuwait’s airport was hit by Iranian drones, injuring dozens and suspending traffic—raising concerns about medical response capacity during attacks. Ebola Watch: Congo’s World Cup warmup in Spain was cancelled over Ebola-related health risks. Sports & Wellbeing: Liverpool defender Ibrahima Konaté speaks openly about depression after personal tragedies, adding to the push for mental health conversations in sport.

Mental Health Policy: France’s health minister says youth mental health care will be fast-tracked, aiming to cut delays for at-risk young people. Obesity Drugs Reimbursement: France becomes the first EU country to reimburse anti-obesity weight-loss drugs for severely obese patients, with coverage starting mid-June. Cancer Research Updates: Final SERENA-6 trial data show that switching to camizestrant after emergent ESR1 mutation detection improves time to second progression in ER+/HER2- advanced breast cancer. Rare Disease & Pharma: Chiesi will highlight real-world outcomes in Fabry disease and nephropathic cystinosis at ERA 2026 and launch the second edition of its Find For Rare research grants. Public Health & Prevention: New research suggests mosquitoes can be conditioned to be attracted to DEET, raising fresh questions about how the repellent works and where vulnerabilities may lie. Clinical Trial Watch: Abivax reports Phase 3 ABTECT maintenance trial results for obefazimod in ulcerative colitis. Care Access: A petition in New Zealand calls for bereavement leave to rise from three to 10 days as lawmakers rewrite employment leave rules.

Mental Health Access in Schools: France will let school staff connect students in distress with local mental-health professionals for an appointment within 48 hours, aiming to reduce emergency psychiatric referrals as hospital beds remain scarce. Obesity Drugs Reimbursement: France is set to become the first EU country to reimburse anti-obesity weight-loss drugs for severely obese patients, with coverage starting mid-June. Ebola Update: WHO reports suspected Ebola cases in DR Congo have fallen sharply to 116 suspected (with 330 confirmed), as many “suspected” alerts are cleared after testing. Cancer Breakthrough: An Oxford-led international early trial reports a new experimental cancer drug (GRWD5769) shrinking tumours by at least 30% in a subset of patients across several common cancer types. Hearing Loss Health Link: A new focus on hearing loss highlights its broader risks for heart health and dementia, alongside emerging treatment approaches. Youth Mental Health Fast-Track: The health ministry’s push to speed mental-health care for young people ties into the school referral plan. Elderly Care Funding Rules: CareContinuity.eu calls for EU rules linking elderly-care funding to measurable delivery of services.

Obesity Drug Reimbursement in France: France is set to become the first EU country to reimburse anti-obesity weight-loss drugs (including Wegovy and Mounjaro) for severely obese patients from mid-June, a major shift for access and affordability. Heatwave Health Risks: Europe’s unusually early May heatwave is already stressing public health systems, with France and the UK reporting heat-related deaths and calls for tighter vigilance during outdoor activity and heat alerts. Cancer Care Breakthrough: Greywolf Therapeutics reported early clinical results for an oral ERAP1 inhibitor (GRWD5769) with cemiplimab, showing objective response rates across multiple hard-to-treat cancer settings. Pharma Deal Watch: Servier is expanding into neuromuscular disorders by acquiring Edgewise Therapeutics’ sevasemten program, targeting rare muscular dystrophies. Ebola Update (DRC/Uganda): Africa CDC says suspected Ebola cases are still high (over 1,100 under investigation) as response plans roll out amid concerns about reliance on external funding. Digital Safety for Youth: Malaysia introduced a ban on social media accounts for under-16s with age verification and platform fines, adding pressure for similar rules across Europe. Climate + Cities: A study links vehicle traffic to extra urban heat in city centers, showing that exhaust and road friction can worsen heat exposure beyond buildings and air conditioning.

Active Nutrition Deal: Lactalis buys Protein Works, adding a Cheshire direct-to-consumer functional nutrition brand (protein shakes, meal replacements, wellness supplements) to its dairy-protein and health nutrition push. Mental Health Care Innovation: Ville-Evrard hospital near Paris is using free therapy-donkey sessions to help psychiatric patients relax and engage in treatment, with staff describing clear early improvements. Cancer Breakthrough: An early trial reports a “smart” experimental drug (GRWD5769) that helps immunotherapy work again by stopping tumour cells from hiding, shrinking tumours by at least 30% in 15 of 26 responders across multiple cancer types. Ebola Vaccine Race (DRC): Non-profits are accelerating development of a vaccine for the Bundibugyo strain in the Democratic Republic of Congo, where WHO says the outbreak is a public health emergency and cases/deaths are rising fast. Public Health & Screens: Sweden’s health agency urges parents to put phones away around children and set screen-free zones, citing links between parental screen habits and children’s behaviour. Obesity Drug Coverage (France): France moves to reimburse anti-obesity weight-loss drugs for severely obese patients, making it the first EU country to do so.

Mental Health Care in France: Ville-Evrard hospital near Paris is using “therapy donkeys” in a free animal-assisted unit, pairing patients with familiar animals to help break the routine of treatment and ease anxiety. Cancer & Nuclear Medicine Industry: Curium will invest over €32m in Saclay to build a new European production line for 177Lu-PSMA-I&T, creating 20 jobs and boosting supply for targeted prostate cancer therapy. Molecular Diagnostics Expansion: ABL Diagnostics expands its UltraGene multiplex qPCR portfolio with a 45-reference range and new respiratory panels, aiming to strengthen pathogen coverage for labs and surveillance. Online Safety Policy: Malaysia starts enforcing a ban on social media accounts for children under 16, requiring age verification and blocking under-16 sign-ups, with fines for non-compliance. Public Health & Travel: KLM cancels flights to Entebbe due to Ebola-related entry and travel restrictions tied to the outbreak in Central Africa. Health-Related Research: A review argues fish can support healthier, more sustainable diets only when consumers choose lower-impact species and use fish to replace higher-impact meats.

Obesity drugs in France: France will reimburse anti-obesity weight-loss drugs for severely obese patients from mid-June, making it the first EU country to do so, a major shift for access to GLP-1-style treatments. Cancer care research: A GU ASCO update on the PEACE-2 phase-three trial discusses whether adding cabazitaxel to radiotherapy (with or without pelvic irradiation) improves outcomes in very high-risk localized prostate cancer. Public health & outbreaks: WHO reports Ebola recoveries in the Congo-Uganda outbreak, while officials continue work on vaccines and treatments. Health workers under fire: Lebanon’s health sector says Israeli attacks on hospitals and medical staff have reached a “dangerous level,” with strikes near Hiram Hospital reported. Care in crisis: Rescuers in Laos race to find two missing miners after heavy rains and equipment failures delay diving in a flooded cave. Safety & environment: Lithuania’s nuclear and radiation safety system is praised after an IAEA review, noting oversight and public communication improvements.

Heatwave & Health Alerts: A record May heatwave is hitting Western Europe hard, with France reporting ozone pollution restrictions and health warnings as temperatures soar and preparedness is questioned. Public Health Research: New lab findings suggest mosquitoes may learn to associate DEET with food, raising fresh concerns about how well common repellents work. Ebola Watch (DR Congo): WHO chief Ghebreyesus visited Bunia as the DRC outbreak continues, with confirmed cases and deaths reported and recovery updates shared. Cross-Border Health/Travel Tech: The EU’s Entry/Exit System is now fully operational, using biometrics to track non-EU entries into Schengen—an issue for seasonal travel flows like Morocco’s Marhaba. Maternal Health (Global): India’s private hospitals are driving a surge in C-sections, with NFHS-6 data showing very high rates in several states. Care & Aging: Maria Shriver highlights gender gaps in Alzheimer’s research and prevention efforts aimed at women. Sports in Extreme Heat: The French Open is being played under brutal conditions, with players reporting heat stress and needing medical breaks.

Antimicrobial Resistance & Climate: A new study links climate change to rising antibiotic resistance in Salmonella, showing resistance genes increasing as temperatures and rainfall patterns shift, raising the risk of harder-to-treat infections. Cancer Treatment Signals: Early results from the ERASMM phase 2 study report strong activity for elranatamab in high-risk smoldering multiple myeloma, with high response rates after 6 cycles. Oncology Trial Update: The CHRONO phase 2 trial finds that extending neoadjuvant chemotherapy from 3 to 6 cycles before surgery in advanced high-grade epithelial ovarian cancer does not improve disease-free survival. EU Public Health Response: The EU has sent first batches of experimental Hantavirus antiviral favipiravir to France, Spain and the Netherlands to support treatment under compassionate-use style protocols. Mosquito Control Rethink: Research suggests mosquitoes can learn to associate common repellents like DEET with feeding, helping explain why protection may fail in some situations. Emergency Care & Safety: A French motorcyclist suffered life-changing injuries after a delivery driver failed to see him at a junction, highlighting road-safety risks.

Imported Mosquito-Borne Illnesses: France recorded 92 imported cases of mosquito-borne diseases (mostly dengue) from May 1–25, all linked to travel abroad, as the tiger mosquito is active in 83 departments. Heatwave Health Risks: Western Europe’s early-season heatwave is pushing temperatures far above seasonal norms, raising alarms for heat-related illness and deaths, including during sports. Obesity Drug Reimbursement: France is set to become the first EU country to reimburse anti-obesity drugs from mid-June, a major shift for access to weight-loss treatment. Ebola Preparedness for Travel: The US, Canada and Mexico announced aligned public health travel measures for travellers from regions at greatest Ebola risk ahead of FIFA World Cup 2026. Public Health & Safety in Emergencies: Specialist divers continued a complex rescue in Laos after villagers were trapped in a flooded cave, with reports of deteriorating health while teams worked to extract survivors. Cancer Care & Research Collaboration: FAPESP will showcase São Paulo–UK scientific work in health and other fields at a London science museum event.

France Health Policy: France will reimburse anti-obesity drugs from mid-June, with the health minister confirming the move to expand access for obese patients. EU Infectious Disease Preparedness: The EU received experimental Favipiravir doses for Hantavirus response, with France, Spain and the Netherlands getting 1,400 tablets under emergency protocols while further procurement is prepared. Ebola Watch (DR Congo): WHO chief Tedros Adhanom Ghebreyesus said the DR Congo Ebola outbreak “can be stopped,” urging ceasefires as conflict and displacement hamper care. Public Health Research: A French-led study suggests mosquitoes can learn to associate DEET with food, raising questions about how well repellents work over time. Sports Medicine & Heat Risks: At Roland-Garros, top seed Jannik Sinner “hit the wall” after dizziness and severe depletion linked to extreme heat, while another player collapsed after a grueling match in sweltering conditions. Global Health & Travel: WHO and partners continue to push for rapid countermeasures as outbreaks drive travel restrictions and emergency responses.

Anti-Obesity Coverage: France will reimburse weight-loss drugs Wegovy and Mounjaro from mid-June, covering patients with BMI ≥35 plus at least one condition or BMI ≥40, easing a €300/month cost burden for many. Public Health & Climate: A record-breaking early heatwave is driving health alerts across Europe, with France and Britain reporting their hottest-ever May days and deaths linked to extreme conditions. Insect-Borne Risk: New research suggests mosquitoes may learn to approach DEET-treated targets, raising questions about how repellents work in real-world use. Heat-Related Hazards: In Île-de-France, processionary caterpillars are surging after hot weather, with authorities warning of skin irritation, allergies, eye inflammation and breathing problems. Medical Innovation: Clarius expands its AI-powered handheld ultrasound portfolio across Europe, including France, aiming to reduce exam variability and speed clinician learning. Infectious Disease Readiness: Valneva says its Lyme vaccine candidate LB6V is progressing toward regulatory submissions after Pfizer topline Phase 3 results.

Oncology Funding: NETRIS Pharma secured €7.25m under Horizon Europe to run a Phase 2b trial of NP137 in head and neck squamous cell carcinoma, aiming to tackle immunotherapy resistance. Infectious Disease Diagnostics: ABL Diagnostics presented at SEIMC 2026 how next-generation sequencing can map CMV antiviral resistance mutations in maribavir-treated immunocompromised patients. Antibiotics Update: Wockhardt received marketing authorisation in India for Zaynich (Zidebactam/Cefepime) for complicated UTIs, including cases with Gram-negative bacteremia, based on Phase 3 results. Public Health Pressure (Heatwave): France reported at least seven heat-related deaths, including fatalities during a fitness race and drownings, as extreme spring temperatures push emergency services. Cross-Border Care Risk: Switzerland’s “No to 10 million” vote could trigger border checks and long queues, potentially disrupting hundreds of thousands of daily cross-border workers, including hospital staff. Care Access: A report flags that patients in France face specialist delays of over five months. Global Health Security: Ebola concerns continue to affect travel and screening, including flight diversions tied to restrictions. ALS Awareness: French actor Pierre Deny died at 69 after a “sudden and severe” ALS battle, renewing attention on the disease and patient support needs.

Obesity Care Expansion: France will partially reimburse Wegovy and Mounjaro (65% rate) for severely obese patients from mid-June, easing a €300/month out-of-pocket burden for many families. Public Health Crisis: WHO warns DR Congo’s Ebola outbreak faces a “catastrophic collision” with conflict in Ituri, with deaths and suspected cases rising faster than containment efforts. Transplant Breakthrough: Four French hospitals coordinated a world-first living-donor kidney transplant with eight people operated on simultaneously in Reims, overcoming donor-recipient incompatibility. Climate & Health Risk: A record-breaking European heatwave is driving health alerts, with France reporting heat-related deaths and authorities urging hydration and limiting exposure. Cardio Nutrition Concern: A large French study links common food preservatives in processed foods to higher risks of high blood pressure and cardiovascular disease. Medical Research Recognition: Three scientists win Hong Kong’s Shaw Prize for targeted therapy breakthroughs in acute promyelocytic leukaemia. ALS Spotlight: French actor Pierre Deny (Emily in Paris) dies at 69 after a sudden, severe ALS battle.

Heatwave Emergency: Western Europe is baking in an unusually early heatwave, with the UK smashing a century-old May record again (35.1°C at Kew) and France reporting heat-linked deaths and drownings as people try to cool off; authorities warn of “heat dome” conditions and dangerous tropical nights where temperatures don’t drop enough to recover. Public Health & Care Access: In the background of the climate shock, health coverage keeps spotlighting access gaps—India’s low-cost eyecare push is helping people with untreated vision problems get glasses for under two dollars. Ebola Watch: Travel and screening rules tied to the Ebola outbreak continue to disrupt flights, including an Air France diversion after a Congo passenger boarded despite US restrictions. Sports & Spotlight: At Roland-Garros, Jannik Sinner and Aryna Sabalenka advanced, while the French Open’s brutal conditions are drawing attention.

Heatwave Health Crisis: Europe’s unusually early heatwave kept breaking records on Tuesday, with the UK hitting 35°C in London and France reporting up to 36°C—while authorities linked several deaths to the extreme temperatures, including drownings as people tried to cool off. Ebola Watch: The International Rescue Committee warns the ongoing Ebola outbreak could become “the deadliest on record,” citing conflict, rapid spread and funding cuts—while new vaccine work and tighter airport screening continue. Public Safety: A train collided with a school minibus in northern Belgium, killing four (including two children) and injuring five more, with investigators still working to determine the cause. Policy Pressure: In the UK, Labour says a crackdown on social media for children is coming “within weeks,” with rules potentially affecting major platforms. Health Travel Alerts: A hantavirus scare tied to a cruise ship has triggered quarantines and hospitalisations in the US, raising questions about preparedness for rare outbreaks arriving via travel hubs.